A blood DNA methylation biomarker for predicting short-term risk of cardiovascular events

Andrea Cappozzo(Politecnico di Milano), Giovanni Fiorito(Italian institute for Genomic Medicine), Salvatore Panico(Federico II University Hospital), Aisling O’Halloran(Trinity College Dublin), Oliver Robinson(Natural Environment Research Council), Rose Anne Kenny(Trinity College Dublin), Thalida Em Arpawong(University of Southern California), Licia Iacoviello(Istituto Neurologico Mediterraneo), Carlotta Sacerdote(Cancer Prevention Institute of California), Frank Kee(Queen's University Belfast), Silvia Polidoro(Cancer Prevention Institute of California), ­Rosario ­Tumino(Azienda Usl 8 Arezzo), Fulvio Ricceri(Cancer Prevention Institute of California), Cathal McCrory(Trinity College Dublin), Ian Young(Toronto Metropolitan University), Bernadette McGuinness(Queen's University Belfast), Giuliana Solinas(University of Sassari), Gareth J. McKay(Queen's University Belfast), Sabina Sieri(Fondazione G.B. Bietti), Amy Jayne McKnight(Queen's University Belfast), Anna Freni Sterrantino(The Alan Turing Institute), Francesca Ieva(Humanitas University), Paolo Vineis(Imperial College London), Vittorio Krogh(Istituti di Ricovero e Cura a Carattere Scientifico), Paolo Chiodini(University of Campania "Luigi Vanvitelli"), Eileen M. Crimmins(University of Southern California)
Clinical Epigenetics
September 29, 2022
Cited by 40


Related Papers